Ab interno micro-stent reduces IOP, glaucoma medication use

SAN FRANCISCO — A micro-stent was beneficial in reducing IOP and medication use alone and in combination with phacoemulsification, according to a study presented here. Manfred R. Tetz, MD, discussed data on the Hydrus micro-stent (Ivantis) at the American Glaucoma Society annual meeting.

Full Story →